Frauenarzt-Praxis Dr. med. Klaus Peters

The practice is running a study that targets acute vaginal infections caused by bacteria and fungi, with the goal of testing a new live biotherapeutic tablet to improve cure rates and reduce symptoms.

• Treatment of bacterial vaginosis
• Management of vulvovaginal candidiasis
• Therapy for mixed bacterial‑fungal infections

The trial compares the investigational product to placebo, seeking a safer first‑line option for women at Frauenarzt-Praxis Dr. med. Klaus Peters.

Research is focused on relieving menstrual cramping by evaluating a botanical extract for its ability to lessen pain in women with primary dysmenorrhea.

• Reduction of menstrual abdominal cramps
• Improvement of quality of life during cycles
• Comparison with placebo over multiple cycles

This study aims to provide an effective, non‑hormonal option for pain management in the gynecologic population served by the clinic.

A vaccine development program is evaluating an mRNA‑based candidate designed to prevent primary infection with cytomegalovirus (CMV) in healthy women of child‑bearing age.

• Prevention of primary CMV infection
• Assessment of vaccine safety and reactogenicity
• Measurement of immune response after three doses

The investigation seeks to offer a future protective strategy against a virus that can cause serious complications during pregnancy, conducted at the Hamburg practice.